Clinical Trial Update: Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of solriamfetol for excessive sleepiness related to shift-work sleep disorder was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shift Work Sleep Disorder

Drugs mentioned

• Sunosi (solriamfetol)

Snippet

Sponsor: Charles A. Czeisler, PhD, MD | Conditions: Excessive Sleepiness, Shift-work Disorder | Phase 4 | Status: TERMINATED | Results posted: 2025-09-24